|
|
 |
|
Viewing report
|
|
|
|
European Point of Care Testing Market
Frost & Sullivan, Nov 2010, Pages: 158
This study focuses on the point of care testing market in Western Europe pertaining to the products that are currently in use and for near patient testing in the fields of cardiac, diabetes, infectious diseases, blood gas and electrolytes, fertility, coagulation and haematology. Revenue forecasting has been done for all the segments. The market sizing and growth rates are pertaining to the seven key regions of Western Europe. The study also attempts to analyse the geographical trends in Europe. Product profiling, market share analysis, competitive analysis and Porter’s five forces analysis has been carried out for all the segments. The study also analyses the drivers, restraints and challenges that influence this industry.
This Frost & Sullivan research service titled European Point of Care Testing Market provides a comprehensive overview of the market including key market drivers and restraints as well as industry challenges. Revenue forecasts are offered in addition to a competitive analysis. The research covers the point of care testing (POCT) market in western Europe pertaining to the bench-top and handheld analysers that are currently in use for point of care testing in clinical settings. In this research, Frost & Sullivan's expert analysts thoroughly examine the following segments: cardiac, diabetes, infectious diseases, blood gas and electrolytes, fertility, coagulation and haematology. The following countries are covered in the research: Germany, France. Italy, Spain, the United Kingdom, Benelux (Belgium, the Netherlands and Luxembourg) and Scandinavia (Sweden, Denmark, Norway and Finland).
Market Overview
Multiple Advantages Promote Rising Popularity of POCT
Advances in analytical technology and healthcare services have led to the significant development of, and demand for, POCT. Some POCT devices have been used in the hospital environment, general practitioner (GP) surgeries and even in home settings (for example, urine and glucose dipsticks and meters) for many years. More recently, the range of analysers and tests available has expanded considerably and the technology has become easier to use and more robust. It is now possible to provide a rapid test result in a timely manner in the immediate vicinity of the patient, such as in the Emergency Department (ED) or the Intensive Care Unit (ICU). The rapidity of obtaining a result can increase clinical effectiveness and contribute to improved outcomes for patients. However, it is imperative that the result provided by the device is accurate and reliable. The improved reliability and range of POCT devices are resulting in their increasing use in community clinics, GP surgeries and the home environment.
“The most significant advantage of POCT is the fact that it produces results within a short duration ranging from seconds to minutes,” notes the analyst of this research. ”This is important in some critical situations such as in the emergency department when the patient is in a critical state.” Rapid return of results aids the clinician in making crucial treatment decisions on the spot. In contrast, conventional lab testing often takes a long time and can delay the treatment of a patient, causing unnecessary expenditures in terms of hospital stays and avoidable agony to the patient. “POCT eliminates the need to transport a specimen to a remote laboratory and prevents errors related to transfer of data and transcription,” states the analyst. “These tests enable the provision of emergency results and simplify the logistics of frequent monitoring.” Hand-held systems can undertake a single assay or a panel of simultaneous tests to offer better-quality patient care, better operational efficiency and increased cost-effectiveness.
Co-operation between Stakeholders Essential to Pushing POCT Implementation
The European point of care market is currently growing at double-digit growth rates, which is significant especially as it comes from an already high base. This growth rate is projected to increase as more European governments widen adoption of POCT, making it more mainstream. However, the implementation and management of programmes for POCT can be difficult because these require input and coordination with many different healthcare professionals. Additionally, POCT must compete with established testing methods and resource availability, as resources are already allocated to labs.
“In the hospital environment, the development and use of POC programmes can require input from various stakeholders such as primary caregivers, POC managers, clinical laboratory personnel and, sometimes, the hospital administration as well,” explains the analyst. “Therefore, the appropriate stakeholders need to be convinced of the value of integrating POCT methods over established programmes.” This is expected to be a key challenge in this market until POCT programmes are streamlined to work seamlessly with existing testing methods and protocols. All the stakeholders will need to make a concerted effort to implement a POCT programme. This trend will gain more momentum as the benefits of this testing modality become progressively more apparent. The UK Government is making significant progress in streamlining the process of implementing POCT programmes. It will not be long before other European governments take their cue and attempt to emulate this pioneering effort.
Market Sectors
Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research:
- Cardiac
- Diabetes
- Infectious diseases
- Blood gas and electrolytes
- Fertility
- Coagulation
- Haematology
By Geography
- Germany
- France
- Italy
- Spain
- the United Kingdom
- Benelux (Belgium, the Netherlands and Luxembourg)
- Scandinavia (Sweden, Denmark, Norway and Finland)
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
